What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.93%Above 5Y avg (0.72%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
64.4%Moderate
Last Ex-Dividend
Jun 25, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.09BCNY
607.72M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
75.33x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
966.97MCNY
143.61M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
6.12%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Beta
0.2780x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-45.32%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
4.09BCNY
607.72M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
4.10BCNY
608.22M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing P/E
75.33x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Forward P/E
21.52x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Price to Sales (TTM)
4.45x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 4.23×.Updated Aug 19, 2026
Price to Book (MRQ)
2.00x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to Revenue
4.24x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Enterprise to EBITDA
114.84x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 17.97×.Updated Aug 19, 2026
Gross Margin
52.37%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 55.56%.Updated Aug 19, 2026
Profit Margin
6.12%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Assets (TTM)
0.90%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Return on Equity (TTM)
2.58%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Revenue (TTM)
966.97MCNY
143.61M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
2.03CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-8.30%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Gross Profit (TTM)
537.22MCNY
79.79M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
227.87MCNY
33.84M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
59.16MCNY
8.79M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-69.49%
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
200.16MCNY
29.73M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
100.00MCNY
14.85M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
0.0800CNYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
0.93%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.72%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
64.41%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 66.67%.Updated Aug 19, 2026
Minority Interest (Equity)
158.63MCNYFY2025 · Dec 31, 2025
Revenue
978.45MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
430.20MCNYFY2025 · Dec 31, 2025
Gross Profit
548.25MCNYFY2025 · Dec 31, 2025
Operating Income
108.93MCNY
16.18M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
83.81MCNYFY2025 · Dec 31, 2025
Income Tax Expense
5.08MCNYFY2025 · Dec 31, 2025
Net Income
78.73MCNYFY2025 · Dec 31, 2025
EBIT
86.81MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
227.87MCNYFY2025 · Dec 31, 2025
Research & Development
129.50MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
111.83MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
6.24MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.00MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1640CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1640CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
476.41MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
476.41MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
78.73MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-595.11KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
111.04MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-65.52MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
312.32MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
78.73MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
3.93MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
49.61MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-21.23MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-176.57MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-602.99MCNYFY2025 · Dec 31, 2025
Sale of Investments
537.24MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-242.32MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
125.83MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-89.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-41.49MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-4.15MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-8.81MCNYFY2025 · Dec 31, 2025
Shares Outstanding
476.35MSharesUpdated Aug 19, 2026
Float Shares
322.70MSharesUpdated Aug 19, 2026
% Held by Insiders
40.36%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
0.78%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
480.30MCNY
71.33M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
1.01CNYUpdated Aug 19, 2026
Total Debt (MRQ)
115.10MCNY
17.09M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.0499x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Current Ratio (MRQ)
4.23x
vs Scientific & Technical Instruments peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
4.52CNYUpdated Aug 19, 2026
Total Assets
2.89BCNY
429.89M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.58BCNYFY2025 · Dec 31, 2025
Total Liabilities
531.12MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.32BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
97.73MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
433.39MCNYFY2025 · Dec 31, 2025
Cash
311.74MCNYFY2025 · Dec 31, 2025
Cash Equivalents
25.70MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
337.44MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
313.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
640.30MCNYFY2025 · Dec 31, 2025
Inventory
174.52MCNYFY2025 · Dec 31, 2025
Accounts Payable
266.14MCNYFY2025 · Dec 31, 2025
Short-term Debt
53.62MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
19.11MCNYFY2025 · Dec 31, 2025
Long-term Debt
92.14MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.93MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
476.35MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.06BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.36BCNY
351.01M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.07CNYUpdated Aug 19, 2026
52-Week High
16.00CNYUpdated Aug 19, 2026
52-Week Change
-45.32%
vs all stocks
Updated Aug 19, 2026
Beta
0.2780x
vs all stocks
Updated Aug 19, 2026
50-Day MA
8.20CNYUpdated Aug 19, 2026
200-Day MA
10.88CNYUpdated Aug 19, 2026
Avg 10-Day Volume
27.87MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
15.25MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
0.1200CNYUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable